No Data
Gilead Sciences Insider Sold Shares Worth $2,459,577, According to a Recent SEC Filing
Mizuho Securities Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $90
$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today
Daily short sale tracking: Warner Bros Discovery's short volume increased by 4 million, with a short sale ratio of 16%
Marengo Therapeutics Enters Clinical Study Collaboration And Supply Agreement With Gilead Sciences
Express News | Marengo Therapeutics: Under Agreement, Gilead Will Provide Trodelvy to Marengo